Stock data
Dermata Therapeutics, Inc. (DRMA)
Dermata Therapeutics, Inc. (DRMA) reported net income of -US$7.56M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | — | — | -US$7.77M | -US$7.56M | — |
| 2024 | — | — | -US$12.51M | -US$12.29M | — |
| 2023 | — | — | -US$8.04M | -US$7.79M | — |
| 2022 | — | — | -US$9.67M | -US$9.61M | — |
| 2021 | — | — | -US$7.86M | -US$7.90M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | — | -US$2.97M | — |
| 2026-03-31 | — | -US$1.85M | — |
| 2025-12-31 | — | -US$1.86M | — |
| 2025-09-30 | — | -US$1.69M | — |
| 2025-06-30 | — | -US$1.70M | — |
| 2025-03-31 | — | -US$2.30M | — |
| 2024-12-31 | — | -US$3.15M | — |
| 2024-09-30 | — | -US$3.17M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.